Status:

COMPLETED

TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma

Lead Sponsor:

Sheba Medical Center

Conditions:

Malignant Lymphoma

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

Study is designed to explore whether the introduction of Thiotepa, to the pre autologous stem-cell transplantation (ASCT) conditioning will reduce toxicity and thus improve outcome following transplan...

Eligibility Criteria

Inclusion

  • Patients with non-Hodgkin's and Hodgkin's lymphoma as confirmed by a pathological biopsy report.
  • Patients who are candidates for Autologous stem-cell transplantation due to refractory or relapsing disease by standard institutional indications and comply with standard transplant eligibility criteria.
  • Age less than physiologic 70 years.
  • Patients with an adequate autologous stem cell collection for transplantation and backup (\>5 x 106 CD34(cluster of differentiation 34)+ cells/kg) .Patients must sign written informed consent.
  • No limitation on bulky disease or bone marrow involvement. No limitation on the number and response to prior therapy. Prior autologous transplantation and/or treatment with rituximab allowed. All prior chemotherapy completed at least three weeks before study treatment

Exclusion

  • Bilirubin \> 3.0 mg/dl, transaminases \> 3 times upper normal limit
  • Creatinine \> 2.0 mg/dl
  • Eastern Cooperative Oncology Group (ECOG) Performance status \> 2
  • Uncontrolled infection
  • Pregnancy or lactation
  • Abnormal lung diffusion capacity (DLCO \< 40% predicted)
  • Severe cardiovascular disease
  • CNS (central nervous system) disease involvement
  • Pleural effusion or ascites \> 1 liter
  • Psychiatric conditions/disease that impair the ability to give informed consent or to adequately co-operate

Key Trial Info

Start Date :

October 9 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03346096

Start Date

October 9 2018

End Date

June 30 2024

Last Update

July 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chaim Sheba Medical Center

Ramat Gan, Israel, 57261